Avingtrans PLC (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss results for the year ended 31st May 2021. Steve talks us through the highlights, explains the Pinpoint-Invest-Exit strategy, the record order book for Booth, what planning permission for the Hayward Tyler Luton site means for the company, more about the medical division, market size and opportunities and what investors can expect from Avingtrans in the next 6-12 months.
Avingtrans PLC designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors. It has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”.